ChemicalBook >?? ???? >ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer. ??? ???
?? ??:
???:
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
???(??):
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer. ??
??
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer. C??? ??, ??, ??
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer. ?? ?? ? ???
???
?? ??
ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer. ?? ??
